counter Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion – Forsething

Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.

About admin